Evidence map›Paper›PMID 29977074›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2018

The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects.

Chadi G Abdallah, Henk M De Feyter, Lynnette A Averill, Lihong Jiang, Christopher L Averill, Golam M I Chowdhury, Prerana Purohit, Robin A de Graaf, Irina Esterlis, Christoph Juchem and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 6 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 6 syntheses or guidelines pooled it, 219 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  11. Trial
  12. Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Trial
  13. Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  14. Reversible alterations of brain acetate metabolism associated with alcohol consumption.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  15. Article
  16. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Chadi G AbdallahClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA. chadi.abdallah@yale.edu.ORCID http://orcid.org/0000-0001-5783-6181
Henk M De FeyterDepartment of Radiology and Biomedical Imaging, Yale Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, USA.
Lynnette A AverillClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.
Lihong JiangDepartment of Radiology and Biomedical Imaging, Yale Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, USA.
Christopher L AverillClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.ORCID http://orcid.org/0000-0001-7575-6142
Golam M I ChowdhuryDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Prerana PurohitClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.
Robin A de GraafDepartment of Radiology and Biomedical Imaging, Yale Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, USA.
Irina EsterlisClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.
Christoph JuchemDepartment of Radiology and Biomedical Imaging, Yale Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, USA.
Brian P PittmanDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
John H KrystalClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.
Douglas L RothmanDepartment of Radiology and Biomedical Imaging, Yale Magnetic Resonance Research Center, Yale University School of Medicine, New Haven, CT, USA.
Gerard SanacoraClinical Neurosciences Division, National Center for PTSD, US Department of Veterans Affairs, West Haven, CT, USA.
Graeme F MasonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Yale University · USUnited States Department of Veterans Affairs · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
Brain Acetate and Ethanol Metabolism in Alcohol Dependence and AbuseR01AA021984 · NIAAA · YALE UNIVERSITY · PI MASON, GRAEME F. · 2013 to 2017
$2.7M
Glial and Synaptic Functions in Major DepressionR01MH112668 · NIMH · YALE UNIVERSITY · PI ABDALLAH, CHADI · 2017 to 2021
$2.4M
13C MRS Studies of Human Brain Mitochondrial Metabolism in Healthy AgingR01AG034953 · NIA · YALE UNIVERSITY · PI ROTHMAN, DOUGLAS LYLE · 2010 to 2013
$1.9M
Examining The Effect Of Ketamine On Glutamate/Glutamine CyclingK23MH101498 · NIMH · YALE UNIVERSITY · PI ABDALLAH, CHADI · 2013 to 2017
$879k
NCRR NIH HHS UL1 RR024139NIAAA NIH HHS R01 AA021984NIA NIH HHS R01 AG034953NIMH NIH HHS K23 MH101498NIMH NIH HHS R01 MH112668U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH101498
6 · The paper itself

Abstract

The ability of ketamine administration to activate prefrontal glutamate neurotransmission is thought to be a key mechanism contributing to its transient psychotomimetic effects and its delayed and sustained antidepressant effects. Rodent studies employing carbon-13 magnetic resonance spectroscopy (

Indexed as

AdultAgedAntidepressive AgentsDepressive DisorderEnergy MetabolismExcitatory Amino Acid AntagonistsFemaleGlutamatesHallucinogensHealthy VolunteersHumansKetamineMagnetic Resonance SpectroscopyMaleMiddle AgedPilot ProjectsAntidepressive AgentsExcitatory Amino Acid AntagonistsGlutamatesHallucinogensKetamine

Identifiers

PMID29977074
PMCPMC6098048
OpenAlexW2811499691

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.